7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
                  
      cash flows from operating activities:
                  
      net income
    30,474,000 14,382,000 -64,323,000 -13,362,000 -2,486,000 -5,744,000 -86,963,000 -38,740,000 -37,995,000 -86,391,000 -26,377,000 -5,796,000 -20,109,000 -5,099,000 
      adjustments to reconcile net income to net cash from operating activities
                  
      depreciation and amortization
    6,954,000 6,049,000 6,202,000 6,317,000 5,914,000 6,272,000 6,214,000 6,015,000 6,356,000 8,675,000 6,416,000 6,483,000 5,599,000 4,431,000 
      benefit from doubtful accounts
                  
      impairment loss on intangible assets and goodwill
                 
      gain on extinguishment of debt
    -22,545,000 -4,891,000        3,133,000 
      loss on divestiture of business
    87,000 5,244,000           
      change in fair value of private warrant liability
    385,000 -50,000 -1,451,000 425,000 1,064,000          
      change in fair value of contingent consideration
    -3,284,000 142,000 -1,351,000 1,051,000 -2,067,000          
      change in fair value of derivatives
    -13,641,000 1,048,000 8,207,000 -1,483,000           
      stock-based compensation
    7,973,000 6,735,000 7,105,000 5,368,000 432,000 6,979,000 6,404,000 6,894,000 6,396,000 5,089,000 9,702,000 5,854,000 9,231,000 5,884,000 
      non-cash interest expense
    -330,000 10,311,000 6,879,000 10,434,000           
      gain on settlement of contingent consideration
    -14,930,000           
      other operating activities
                  
      change in operating assets and liabilities, net of acquisitions and divestitures
                  
      accounts receivable
    1,520,000 -127,000 -1,109,000 -439,000 2,374,000 -2,374,000 -1,589,000 2,619,000 3,753,000 1,268,000 -8,611,000 -1,296,000 2,519,000 -407,000 
      reinsurance balance due
    11,059,000 1,586,000 -28,216,000 8,174,000 20,068,000          
      deferred policy acquisition costs
    -967,000 -296,000 4,143,000 6,752,000           
      accounts payable
    -607,000 2,011,000 -2,116,000 -3,511,000 -287,000 -151,000 2,998,000 -69,000 -449,000 3,978,000 -5,277,000 1,051,000 11,505,000 -1,867,000 
      accrued expenses and other current liabilities
    1,490,000 -4,326,000 -9,656,000 1,829,000 7,937,000 1,583,000 -12,296,000 1,390,000 1,482,000 -10,359,000 5,503,000 -3,145,000 -19,012,000 6,323,000 
      losses and loss adjustment expense reserves
    -32,825,000 -32,610,000 20,660,000 17,057,000 -34,272,000          
      other insurance liabilities, current
    -34,613,000 6,553,000 26,457,000 9,158,000 -22,598,000          
      deferred revenue
    -3,214,000 28,470,000 7,324,000 -33,017,000 -16,887,000 8,795,000 10,609,000 -24,100,000 -5,346,000 33,990,000 39,838,000 -2,228,000 10,608,000 27,124,000 
      refundable customer deposits
    -497,000 -1,354,000 -1,560,000 -2,034,000 -1,677,000 -4,187,000 -3,454,000 -4,607,000 1,944,000 621,000 2,560,000 1,412,000 -1,104,000 -1,168,000 
      other assets and liabilities
    3,860,000 -2,441,000 -1,688,000 11,122,000 -4,849,000          
      net cash from operating activities
    -26,602,000 12,425,000 -25,970,000 8,465,000 -40,969,000 83,675,000 13,254,000 -22,031,000 -4,928,000 -10,502,000 10,985,000 -13,291,000 6,940,000 -10,945,000 
      capex
    -3,874,000 -3,377,000 -3,188,000 -2,356,000 -2,397,000 -2,292,000 -2,624,000 -2,783,000 -2,661,000 -2,754,000 -2,294,000 -2,741,000 -1,474,000 -1,168,000 
      free cash flows
    -30,476,000 9,048,000 -29,158,000 6,109,000 -43,366,000 81,383,000 10,630,000 -24,814,000 -7,589,000 -13,256,000 8,691,000 -16,032,000 5,466,000 -12,113,000 
      cash flows from investing activities:
                  
      purchases of property and equipment
    -192,000 -245,000 -45,000 -41,000 -75,000 -104,000 -316,000 -356,000 -364,000 -447,000 -372,000 -1,167,000 -384,000 -49,000 
      capitalized internal use software development costs
    -3,682,000 -3,132,000 -3,143,000 -2,315,000 -2,322,000 -2,188,000 -2,308,000 -2,427,000 -2,297,000 -2,307,000 -1,922,000 -1,574,000 -1,090,000 -1,119,000 
      purchases of short-term and long-term investments
    -12,777,000 -78,955,000   -31,164,000 -36,249,000 -18,192,000 -5,410,000 -33,060,000 -5,885,000 -4,726,000 -8,835,000 -4,880,000 -9,650,000 
      maturities, sales of short-term and long-term investments
    23,799,000 21,359,000   11,511,000          
      proceeds from sale of business
    522,000 10,348,000           
      acquisitions, net of cash acquired
               -77,749,000 -50,798,000 
      net cash from investing activities
    7,148,000 -60,973,000 -3,933,000 12,697,000 -22,050,000 -26,253,000 -2,803,000 -5,147,000 -33,234,000 -8,040,000 -30,327,000 -8,077,000 -78,776,000 -53,359,000 
      cash flows from financing activities:
                  
      proceeds from line of credit
                  
      proceeds from advance funding
                 
      repayments of advance funding
        -1,171,000          
      proceeds from issuance of debt
                 
      repayments of principal
    -169,000 -20,049,000 -3,150,000         
      cash paid for debt issuance costs
        -44,000          
      repurchase of stock
                 
      other financing activities
                  
      net cash from financing activities
    -442,000 -20,139,000 -625,000 -2,501,000 -1,463,000 -558,000 100,246,000 -7,274,000 -10,227,000    -19,203,000 327,712,000 
      net change in cash and cash equivalents & restricted cash and cash equivalents
    -19,896,000 -68,687,000 -30,528,000 18,661,000           
      cash and cash equivalents & restricted cash and cash equivalents, beginning of period
    297,232,000           
      cash and cash equivalents & restricted cash and cash equivalents, end of period
    -19,896,000 -68,687,000 -30,528,000 315,893,000           
      benefit from (recovery of) doubtful accounts
     -39,000             
      other
     -1,074,000 -1,083,000 -799,000 55,000 197,000 563,000 242,000 405,000 400,000 16,000 64,000 2,434,000 100,000 
      supplemental schedule of non-cash investing and financing activities
                  
      non-cash reduction of convertible notes
     23,180,000 5,000,000           
      non-cash reduction in advanced funding arrangement obligations
     94,000           
      supplemental disclosures
                  
      cash paid for interest
     457,000 11,087,000 969,000           
      income tax refunds paid
     8,000             
      purchases, maturities, sales of short-term and long-term investments
       4,705,000           
      income tax refunds received
       -174,000           
      change in fair value of earnout liability and derivatives
        1,777,000          
      capped call transactions
                  
      proceeds from exercises of warrants
                -31,000 
      income tax withholdings paid upon vesting of restricted stock units
                  
      net change in cash, cash equivalents, and restricted cash
        -64,482,000 56,864,000 110,697,000 -34,452,000 -48,389,000 -5,083,000 -20,958,000 -21,757,000 -91,039,000  
      cash, cash equivalents, and restricted cash, beginning of period
        228,605,000 324,792,000 
      cash, cash equivalents, and restricted cash end of period
        -64,482,000 56,864,000 110,697,000 194,153,000 -48,389,000 -5,083,000 -20,958,000 303,035,000 -91,039,000 263,408,000 
      interest expense
         10,386,000 8,294,000 1,534,000 -17,000 -52,000 1,293,000 1,046,000 2,320,000 
      prepaid expenses and other current assets
         -16,316,000 1,170,000 -10,826,000 1,151,000 1,461,000 -1,009,000 -6,749,000 -5,413,000 -1,564,000 
      long-term insurance commissions receivable
         -171,000 -362,000 -875,000 -335,000 -1,469,000 -1,400,000 -1,540,000   
      supplemental schedule of non-cash financing activities
                  
      non-cash consideration for acquisitions
                  
      gain on remeasurement of private warrant liability
          -15,000 -345,000 -95,000 -124,000 -4,078,000 -10,189,000   
      gain on remeasurement of contingent consideration
          -2,656,000 -154,000 1,693,000 565,000 1,481,000 3,205,000 -1,864,000 -66,000 
      gain on remeasurement of earnout liability and derivatives
                  
      proceeds from exercises of stock options
                  
      proceeds from sale of common stock
                  
      payments of acquisition-related contingent consideration
                  
      amortization of operating lease right-of-use assets
                  
      loss on sale and impairment of property, equipment, and software
                  
      gain on remeasurement of earnout liability
                  
      amortization of investment premium/accretion of discount
                  
      net realized losses on investments
                  
      operating lease liabilities, non-current
                  
      repayments of principal and related fees
           -499,000 -5,000,000 -150,000 -4,000,000 -42,815,000 
      loss on remeasurement of debt
                  
      gain on divestiture of businesses
                  
      loss on remeasurement of legacy porch warrants
                  
      deferred income tax
                  
      proceeds from recapitalization and pipe financing
                  
      distribution to stockholders
                  
      transaction costs - recapitalization
                  
      proceeds from debt issuance, net of fees
                 
      proceeds from issuance of redeemable convertible preferred stock, net of fees
                  
      capped call transaction
                  
      proceeds from exercises of stock options and legacy porch warrants
                  
      deferred income tax benefit
                  
      loss on sale and impairment of long-lived assets
                  
      net cash (used) provided by financing activities
              -1,616,000 -389,000   
      contingent consideration - business combination
                  
      non-refundable deposit for acquisition
               -4,950,000   
      settlement of contingent consideration related to a business acquisition
                  
      loss on remeasurement of private warrant liability
                  
      loss on remeasurement of earnout liability
                  
      amortization of premium/accretion of discount
                  
      divestiture of businesses net of cash disposed
                  
      loss on remeasurement of warrants
                 -2,691,000 
      deferred offering costs
                  
      net realized (gains) losses on investments
                  
      settlement of contingent consideration related to a business combination
                  
      change in cash, cash equivalents, and restricted cash
                  
      warrants issued for services
                  
      deferred taxes
                  
      divestiture of businesses, net of cash disposed
                  
      proceeds from exercises of stock options and warrants
                  
      adjustments to reconcile net income to net cash from operating activities:
                  
      investment income from investments held in trust account
                  
      changes in operating assets and liabilities:
                  
      prepaid expenses
                  
      accrued expenses
                  
      franchise tax payable
                  
      income tax payable
                  
      cash deposited in trust account
                  
      proceeds from sale of class b common stock to sponsor
                  
      proceeds from note payable to related party
                  
      repayment of note payable to related party
                  
      proceeds received from initial public offering, gross
                  
      proceeds received from sale of private placement warrants
                  
      offering costs paid
                  
      net increase in cash
                  
      cash - beginning of the period
                  
      cash - end of the period
                  
      supplemental disclosure of noncash investing and financing activities:
                  
      deferred underwriting commissions associated with the initial public offering
                  
      offering cost included note payable to related party
                  
      offering cost included in accounts payable
                  
      offering cost included in accrued expenses
                  
      value of common stock subject to possible redemption
                  
      ●
                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.